Stimulating autoantibodies against the angiotensin II type 1 receptor are not associated with preeclampsia in Mexican-Mestizo women

Journal of Hypertension

Volumn 28, Issue 4, 2010, Pages 834-841

  Leaños Miranda, Alfredo ^a   Campos Galicia, Inova ^a   Alvarez Jiménez, Guadalupe ^a   Isordia Salas, Irma ^b   Rivera Leaños, Roxana ^a   Ulloa Aguirre, Alfredo ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Hospital General Regional Gabriel Mancera   (Mexico)

Author keywords

Angiotensin II type 1 receptor; Autoantibody; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; IMMUNOGLOBULIN G; LUCIFERASE; NUCLEAR FACTOR;

ADULT; ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMBRYO; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEXICO; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 78650780668     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283376cc6     Document Type: Article

References (26)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357:53-56.
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
3. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95:24-28.
4. 1 receptor. J Clin Invest 1999; 103:945-952.
5. Xia Y, Wen H, Bobst S, Day MC, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 2003; 10:82-93.
6. 1 receptor in patients with preeclampsia. Can J Physiol Pharmacol 2003; 81:79-83.
7. Dechend RV, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000; 101:2382-2387.
8. Dechend RC, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003; 107:1632-1639.
9. 2+ mobilization through angiotensin receptor activation. Circulation 2004; 110:1612-1619.
10. Bobst SM, Day MC, Gilstrap LC III, Xia Y, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptor on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 2005; 18:330-3356.
11. Zhou CC, Ahmad S, Mi T, Abbasi S, Xia L, Day MC, et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008; 51:1010-1019.
12. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, et al. Angiotensin receptor agonistic autoantibodies induce preeclampsia in pregnant mice. Nat Med 2008; 14:855-862.
13. Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab 2006; 91:2424-2427.
14. Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, et al. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009; 53:393-398.
15. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss HP, Fabeer R, et al. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 2005; 46:1275-2127.
16. ACOG Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin no. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99:159-167.
17. Leaños-Miranda A, Márquez-Acosta J, Romero-Arauz F, Cárdenas-Mondragón MG, Rivera-Leaños R, Isordia-Salas I, et al. Protein:creatinine ratio in random urine samples is a reliable marker of increased 24-h protein excretion in hospitalized women with hypertensive disorders of pregnancy. Clin Chem 2007; 53:1623-1628.
18. Zhang J, Bowes WA Jr. Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol 1995; 86:200-208.
19. Stepan H, Walther T. Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension 2007; 50:e3.
20. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003; 5:80-93.
21. Nieter JP, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 2006; 33:263-268.
22. Kuwana N, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994; 37:902-906. (Pubitemid 24184543)
23. Kuwana N, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999; 42:465-474.
24. Quintero-Del Rió AI, Bacino D, Kelly J, Aberle T, Harley JB. Familial systemic lupus erythematosus: a comparison of clinical manifestations and antibody presentation in three ethnic groups. Cell Mol Biol 2001; 47:1223-1227.
25. Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, et al. Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44:2367-2370.
26. López-Jaramillo P, Herrera JA, Arenas-Mantilla M, Jáuregui IE, Mendoza MA. Subclinical infection as a cause of inflammation in preeclampsia. Am J Ther 2008; 15:373-376.